AtaiBeckley (ATAI) Receivables - Other (2020 - 2025)

AtaiBeckley's (ATAI) quarterly Receivables - Other came in at $326000.0 in Q3 2021, down 63.78% quarter-over-quarter from $900000.0 in Q4 2020.

AtaiBeckley (ATAI) Receivables - Other (2020 - 2025) Analysis & Trends

AtaiBeckley's Receivables - Other history runs 1 years deep, the most recent figure standing at $300000.0 for Q4 2025.

Receivables - Other for Q3 2021 came in at $326000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2021 was $326000.0 (changed N/A YoY), and the FY2020 annual result was $900000.0, changed N/A from the prior year.
Receivables - Other was $300000.0 for Q4 2025 at AtaiBeckley.
In the past five years, Receivables - Other ranged from a high of $900000.0 in Q4 2020 to a low of $326000.0 in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	AtaiBeckley	1.45 Bn	1.45 Bn	-

Download Data